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Abstract 
The time-varying reproduction number (Rt: the average number secondary infections caused by each 
infected person) may be used to assess changes in transmission potential during an epidemic. Since 
new infections usually are not observed directly, it can only be estimated from delayed and potentially 
biased data. We estimated Rt using a model that mapped unobserved infections to observed test-
positive cases, hospital admissions, and deaths with confirmed Covid-19, in seven regions of England 
over March through August 2020. We explored the sensitivity of Rt estimates of Covid-19 in England to 
different data sources, and investigated the potential of using differences in the estimates to track 
epidemic dynamics in population sub-groups. 
Our estimates of transmission potential varied for each data source. The divergence between estimates 
from each source was not consistent within or across regions over time, although estimates based on 
hospital admissions and deaths were more spatio-temporally synchronous than compared to estimates 
from all test-positives. We compared differences in Rt with the demographic and social context of 
transmission, and found the differences between Rt may be linked to biased representations of sub-
populations in each data source: from uneven testing rates, or increasing severity of disease with age, 
seen via outbreaks in care home populations and changing age distributions of cases. 
We highlight that policy makers should consider the source populations of Rt estimates. Further work 
should clarify the best way to combine and interpret Rt estimates from different data sources based on 
the desired use. 
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Background 
Since its emergence in 2019, the novel coronavirus SARS-CoV-2 has caused over six million cases of 
disease (Covid-19) worldwide within six months [1]). Its rapid initial spread and high death rate prompted 
global policy interventions to prevent continued transmission, with widespread temporary bans on social 
interaction outside the household [2]. Introducing and adjusting such policy measures depends on a 
judgement in balancing continued transmission potential with the multidimensional consequences of 
interventions. It is therefore critical to inform the implementation of policy measures with a clear and 
timely understanding of ongoing epidemic dynamics [3,4]. 
In principle, transmission could be tracked by directly recording all new infections. In practice, real-time 
monitoring of the Covid-19 epidemic relies on surveillance of indicators that are subject to different 
levels of bias and delay. In England, widely available surveillance data across the population includes: 
1) the number of positive tests, biased by changing test availability and practice, and delayed by the 
time from infection to symptom onset (if testing is symptom-based), from symptom onset to a decision 
to be tested and from test to test result; 2) the number of new hospital admissions, biased by differential 
severity that triggers care seeking and hospitalisation, and additionally delayed by the time to develop 
severe diseases; and 3) the number of new deaths due to Covid-19, biased by differential risk of death 
and the exact definition of a Covid-19 death, and further delayed by the time to death. 
 
Each of these indicators provides a different view on the epidemic and therefore contains potentially 
useful information. However, any interpretation of their behaviour needs to reflect these biases and lags 
and is best done in combination with the other indicators. One approach that allows this in a principled 
manner is to use the different data sets to separately track the time-varying reproduction number, Rt, 
the average number of secondary infections generated by each new infected person [5]. Because Rt 
quantifies changes in infection levels, it is independent of the level of overall ascertainment as long as 
this does not change over time or is explicitly accounted for [6]. At the same time, the underlying 
observations in each data source may result from different lags from infection to observation. However, 
if these delays are correctly specified then transmission behaviour over time can be consistently 
compared via estimates of Rt. 
Different methods exist to estimate the time-varying reproduction number, and in the UK a number of 
mathematical and statistical methods have been used to produce estimates used to inform policy [7,8]. 
Empirical estimates of Rt can be achieved by estimating time-varying patterns in transmission events 
from mapping to a directly observed time-series indicator of infection such as reported symptomatic 
cases. This can be based on the the probabilistic assignment of transmission pairs [9], the exponential 
growth rate [10], or the renewal equation [11,12]. Alternatively, Rt can be estimated via mechanistic 
models which explicitly compartmentalise the disease transmission cycle into stages from susceptible 
through exposed, infectious and recovered [13,14]. This can include accounting for varying population 
structures and context-specific biases in observation processes, before fitting to a source of observed 
cases. Across all methods, key parameters include the time after an infection to the onset of symptoms 
in the infecting and infected, and the source of data used as a reference point for earlier transmission 
events [15,16]. 
In this study, we used a modelling framework based on the renewal equation, adjusting for delays in 
observation to estimate regional and national reproduction numbers of SARS-Cov-2 across England. 
The same method was repeated for each of three sources of data that are available in real time. After 
assessing differences in Rt by data source, we explored why this variation may exist. We compared the 
divergence between Rt estimates with spatio-temporal variation in case detection, and the proportion 
at risk of severe disease, represented by the age distribution of test positive cases and hospital 
admissions and the proportion of deaths in care homes. 
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Methods 
Data management 
Three sources of data provided the basis for our Rt estimates. Time-series case data were available by 
specimen date of test. This was a de-duplicated dataset of Covid-19 positive tests notified from all 
National Health Service (NHS) settings (Pillar One of the UK Government’s testing strategy, [17]) and 
by commercial partners in community settings outside of healthcare (Pillar Two). Hospital admissions 
were also available by date of admission if a patient had tested positive prior to admission, or by the 
day preceding diagnosis if they were tested after admission. Death data were available by date of death 
and included only those which occurred within 28 days of a positive Covid-19 test in any setting. All 
data were publicly available and taken from the UK government source [18,19], and were aggregated 
to the seven English regions used by the NHS. 
To provide context for Rt estimates, we sourced weekly data on regional and national test positivity 
(percentage positive tests of all tests conducted) from Public Health England [20], available as weekly 
average percentages from 10th May. From the same source, we also identified the age distributions of 
cases admitted to hospital and all test-positive cases. Hospital admissions by age were available as 
age bands with rates per 100,000, so we used regional population data from 2019 [21] to approximate 
the raw count.  We separately sourced daily data on the number of deaths in care homes by region 
from March, available from 12th April [22]. Care homes are defined as supported living facilities 
(residential homes, nursing homes, rehabilitation units and assisted living units). Data were available 
by date of notification, which included an average 2-3 day lag after the date of death. We also drew on 
a database which tracked Covid-19 UK policy updates by date and area [23]. 
Rt estimation 
We estimated Rt using EpiNow2 version 1.2.0, an open-source package in R [24,25]. This package 
implements a Bayesian latent variable approach using the probabilistic programming language Stan 
[26], which works as follows. The initial number of infections were estimated as a free parameter with a 
prior based on the initial number of cases, hospital admissions or deaths, respectively. For each 
subsequent time step, previous imputed infections were summed, weighted by an uncertain generation 
time probability mass function, and combined with an estimate of Rt to give the prevalence at time t 
[11]. These infection trajectories were mapped to reported case counts by convolving over an uncertain 
incubation period and report delay distribution [24], and a negative binomial observation model 
combined with a multiplicative day of the week effect (with an independent effect for each day of the 
week).Temporal variation was controlled using an approximate Gaussian process [27] with a squared 
exponential kernel. The length scale and magnitude of the kernel were estimated during model fitting. 
Each region was fitted independently using Markov-chain Monte Carlo (MCMC). Eight chains were used 
with a warmup of 1,000 samples and 2,000 samples post warmup. Convergence was assessed using 
the R hat diagnostic [24,26]. 
We used a gamma distributed generation time with mean 3.6 days (standard deviation (SD) 0.7), and 
SD of 3.1 days (SD 0.8), sourced from [28]. Instead of the incubation period used in the original study 
(which was based on fewer data points), we refitted using a log-normal incubation period with a mean 
of 5.2 days (SD 1.1) and SD of 1.52 days (SD 1.1)[29]. This incubation period was also used to convolve 
from unobserved infections to unobserved symptom onsets (or a corresponding viral load in 
asymptomatic cases) in the model. We estimated both the delay from onset to positive test (either in 
the community or in hospital) and the delay from onset to death as log-normal distributions using a 
subsampled Bayesian bootstrapping approach (with 100 subsamples each using 250 samples) from 
given data on these delays.  Our delay from date of onset to date of positive test (either in the community 
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or in hospital) was taken from a publicly available linelist of international cases [30]. We removed 
countries with outlying delays (Mexico and the Philippines). The resulting delay data had a mean of 4.4 
days and standard deviation (SD) 5.6. For the delay from onset to death we used data taken from a 
large observational UK study [31]. We re-extracted the delay from confidential raw data, with a mean 
delay of 14.3 days (SD 9.5). There was insufficient data available on the various reporting delays to 
estimate spatially- or temporally-varying delays, so they were considered to be static over the course 
of the epidemic. See [12,24] for further details on the approach.  
Comparison of Rt estimates 
We compared Rt estimates by data source, plotting each by region over time. To avoid the first epidemic 
wave obscuring visual differences, all plots were limited to the earliest date that any Rt estimate for 
England crossed below 1 after the peak. We also identified the time at which each Rt estimate fell below 
1, the local minima and maxima of median Rt estimates, and the number of times in the time-series that 
each Rt estimate crossed its own median, and compared these across regions and against the total 
count of the raw data.  
We investigated correlations between Rt and the demographic and social context of transmission. We 
used linear regression to assess whether the level of raw data count influenced oscillations in Rt. We 
assessed the influence of local outbreaks using test positivity. We used a 5% threshold for positivity as 
the level at which testing is either insufficient to keep pace with widespread community transmission 
[32], or where outbreaks have already been detected and tests targeted to those more likely to be 
positive. We plotted this against raw data and Rt, and also used linear regression to test the association. 
We interpreted results in light of known outbreaks and policy changes. We plotted and qualitatively 
assessed variation in Rt against the age distribution of cases over time, and similarly explored patterns 
in Rt against the qualitative proportion of cases to all deaths. The latter was not assessed quantitatively 
due to differences in reference dates [22]. With the exception of sampling the delay from onset to death 
(held confidentially), end to end code to reproduce this analysis is available [33]. 
Results 
Across England, the Covid-19 epidemic peaked at 4,798 reported test-positive cases (on the 22nd 
April), 3,099 admissions (1st April), and 975 deaths (8th April) per day (figure 1A)). Following the peak, 
a declining trend continued for daily counts of admissions and deaths, while daily case counts from all 
reported test-positive cases increased from July and had more than tripled by August (from 571 on 30th 
June to 1,929 on 1st September). Regions followed similar patterns over time to national trends. 
However, in the North East and Yorkshire, Midlands, and North West, incidence of test-positive cases 
did not decline to near the count of admissions as in other regions, and also saw a small temporary 
increase during the overall rise in case counts in early August. 
[Figure 1] 
Following the initial epidemic peak in mid-March, the date at which Rt crossed below 1 varied by both 
data source and geography (figure 1B, figure 2). The first region to cross into a declining epidemic was 
London, on the 26th March according to an Rt estimated from deaths (where the lower 90% CrI crossed 
below 1 on the 24th and the upper CrI on the 28th March). However, as much as spatial variation, the 
data sources used to estimate Rt influenced the earliest date of epidemic decline. Rt estimated from 
hospital admissions gave the earliest estimate of a declining epidemic, while using all test-positive 
cases to estimate Rt took the longest time to reach a declining epidemic, in all but one region (East of 
England). This difference by data source varied by up to 21 days in the North East and Yorkshire, where 
hospital admissions gave a median Rt estimate under 1 on the 1st April (90%CrIs 31st March, 2nd 
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April), but the median Rt from test-positive cases crossed 1 on only the 22nd April (90%CrIs 1st April, 
25th April). 
[Figure 2] 
When not undergoing a clear state change, Rt estimates from all data sources appeared to oscillate, 
with oscillations damped when Rt estimates were transitioning to what appeared to be new levels. In 
England and all NHS regions, test-positive cases showed evidence of larger damped oscillations from 
July when a state change occurred to Rt > 1. In England, Rt from test-positive cases increased from 
0.99 (90%CrI 0.94-1.04) on 30th June to 1.37 (90%CrI 1.31-1.1.44) on 27th August. Meanwhile, the 
timing and duration of oscillations did not align between Rt estimates (figure 1B). In some regions, the 
difference between Rt estimates held consistently over time, such as between Rt from admissions and 
deaths in the South East. In other regions such as the Midlands this was not the case, with the 
divergence between the Rt from test-positive cases, admissions, and deaths each varying over time. Rt 
estimates from test-positive cases were the most likely to diverge from estimates derived from other 
data sources across all regions. Across all regions, Rt estimates from deaths had larger damped 
oscillations compared to estimates from test-positive cases or hospital admissions. However, 
oscillations in Rt did not appear to be linked to the level of raw data counts in each source (SI figure 2).  
 
More rapid oscillations in Rt from test-positive cases appeared to be linked to targeted testing of case 
clusters, seen in high test positivity (table SI2). Both the North East and Yorkshire and the Midlands 
saw more frequent oscillations in Rt from test-positive cases than other regions. The Rt from cases 
crossed its own median 10 times over the time-series in both regions, while in all other NHS regions 
this averaged 6 times, and oscillations in Rt from cases also had a shorter duration in the North East 
and Yorkshire and the Midlands compared to other regions (table SI1). Across all regions, 84% of weeks 
with over 5% positivity (N=19) were in the North East and Yorkshire and the Midlands (figure 2A). In 
these regions, positivity peaked on the week of 9th May at 14% and 12% respectively, and overall 
averaged 6% (95%CI 4.4-7.6%) and 5.9% (95%CI 4.6-7.2%, weeks of 10th May to 22nd August) 
respectively. High test positivity is likely to have resulted from targeted testing among known local 
outbreaks in these regions. In the Midlands, these included local restrictions and increased testing 
across Leicester and in a Luton factory (restrictions between 4th and 25th July [34]). In Yorkshire case 
clusters were detected with local restrictions in Bradford, Calderdale, and Kirklees (with restrictions from 
5 August [35]). 
In England, a divergence between Rt from cases versus Rts from deaths and admissions coincided with 
a decline in the age distribution among all test-positive cases in England to a younger population (figure 
SI1A). From mid-April to June, national estimates of Rt from test-positive cases remained around the 
same level as those from admissions or deaths, while after this, cases diverged to a higher steady state 
(figure 1A). On the 23rd May, the median Rt from cases matched that of deaths at 0.83 (both with 90% 
CrIs 0.78-0.89), but this was followed by a 78 day period before the two estimates were again 
comparable, on 8th August. Over this period the median Rt from cases was on average 14% higher 
(95%CI 12-15%). Meanwhile, the share of test-positive cases under age 50 increased from under one-
quarter of cases in the week of 28 March (24%, N=16,185), to accounting for nearly three-quarters of 
cases by 22nd August (77%, N=6,733). While the percentage of test-positive cases aged 20-49 
increased consistently from April to August, the 0-19 age group experienced a rapid increase over mid-
May through July, increasing by a mean 1% each week over May 9th through August 1st (from 4% of 
18,774 cases to 14.8% of 5,017 cases).  
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Similarly, Rt from admissions in England oscillated over June through July, potentially linked to the age 
distribution of hospital admissions. From 0.92 (90%CrI 0.87-0.98) on the 11th June, Rt from admissions 
fell to 0.8 (90%CI 0.75-0.85)) on the 27th June. In contrast, this transition was not observed in the Rt 
estimate based on test-positive cases (figure 1A). Older age groups dominated Covid-19 hospital 
admissions, where 0-44 years never accounted for more than 12.8% of hospital-based cases (a 
maximum in the week of 22nd August, N=690; figure SI2B). While the proportion of hospital admissions 
aged 75+ remained steady over May through mid-June, this proportion appeared to oscillate over July 
through August (standard deviation of weekly percentage at 6.1 over June-August, compared to 5.4 in 
months March-May). These variations were not seen in the proportion aged 70+ in the test-positive 
case data, which saw a continuous decline from 30% at the start of June to 7% by August. 
Rt estimated from either admissions or deaths experienced near-synchronous local peaks across 
regions over April and May. We compared this Rt from deaths with its source data and a separate 
regional dataset of deaths in care homes. In the South East and South West, the Rt from deaths rose 
over April, with a peak of Rt in early May. In the South West, the median Rt estimate from deaths 
increased by 0.04 from 22nd April to 7th May (from 0.8 (90%CrI 0.72-0.88) to 0.84 (90%CrI 0.76-0.95)); 
and by 0.06 from the 17th April to 4th May in the South East (from 0.82 (90%CrI 0.77-0.9) to 0.88 
(90%CrI 0.72-0.88)). In both these regions, this early May peak in Rt from deaths coincided with similarly 
rising Rts from hospital admissions, while the reverse trend was seen in Rt from cases. In all regions, 
care home deaths peaked over the 22nd-29th April (by date of notification; figure SI3). This was later 
than regional peaks in the raw count of all deaths in any setting (which peaked between the 8th-16th 
April, by date of death), even accounting for a 2-3 day reporting lag. This meant that the proportion of 
deaths from care homes varied over time, where in the South East and South West, deaths in care 
homes appeared to account for nearly all deaths for at least the period mid-May to July.  
Discussion 
We estimated the time-varying reproduction number for Covid-19 over March through August across 
England and English NHS regions, using test-positive cases, hospital admissions, and deaths with 
confirmed Covid-19. Our estimates of transmission potential varied for each of these sources of 
infections, and the divergence between estimates from each data source was not consistent within or 
across regions over time, although estimates based on hospital admissions and deaths were more 
spatio-temporally synchronous than compared to estimates from cases. We compared differences in Rt 
estimates to the extent and context of transmission, and found that the difference between Rt from 
cases, admissions, and deaths may be linked to uneven rates of testing, the changing age distribution 
of cases, and outbreaks in care home populations.  
Rt varied by data source, and the extent of variation itself differed by region and over time. Following 
the initial epidemic peak in mid-March, the date at which Rt crossed below 1 varied by both data source 
and geography, following which Rt estimates from all data sources varied when not undergoing a clear 
state change. The differences in these oscillations by data source may indicate different underlying 
causes. This implies that each data source was influenced differently by changes in sub-populations 
over time. 
 
Increasingly rapid oscillations in Rt from test-positive cases were associated with higher test-positivity 
rates. Increasing test-positivity rates could be an indication of inconsistent community testing, with the 
observation of an initial rise in transmission amplified by expanded testing and local interventions where 
a cluster of new, mild cases has been identified [17]. This targeted testing may drive regionally localised 
instability in case detection and resulting Rt estimates but may not reflect changes in underlying 
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transmission. This is a limitation of monitoring epidemic dynamics using test-positive surveillance data 
in areas where testing rates vary across the population and over time. This also suggests that Rt from 
admissions may be more reliable than that from all test-positive cases for indicating the relative intensity 
of an epidemic over time [36]. 
We hypothesised that variations in Rt estimates based on data reflecting more severe outcomes 
(hospital admissions and deaths) were related to changes in the age distribution of cases over time, 
because age is associated with severity [37]. We found that from June onwards, Rt from all test-positive 
cases appeared to increasingly diverge away from Rt from admissions and deaths, transitioning into a 
separate, higher, steady state. This was followed by the observed age distribution of all test-positive 
cases becoming increasingly younger, while the age distribution of admissions remained approximately 
level. Because of the severity gradient, this suggested the Rts from all test-positive cases and 
admissions were more biased by the relative proportion of younger cases and older cases respectively 
than the Rt from admissions or deaths.  
Similarly, all regions saw a near-synchronous local peak in Rt from hospital admissions over spring, 
which was not observed in Rt from test-positive cases. This may have reflected the known widespread 
regional outbreaks in care homes, with an older population who are more likely to experience fatal 
outcomes, and less likely to appear for community testing or in hospital admissions, than the general 
population [38–40] 
Our analysis was limited where data or modelling assumptions did not reflect underlying differences in 
transmission. Rt estimates can become increasingly uncertain and unstable with lower case counts. 
Further, estimated unobserved infections were mapped to reported cases or deaths using two uncertain 
delay distributions: the time from infection to test in the community or hospital, and a longer delay from 
infection to death. A mis-specified delay distribution would have created bias in the temporal distribution 
of all resulting Rt estimates, with estimated dates of infection and Rt, incorrectly shifted too much or little 
in time compared to the true infection curve. This may have been observed in the Rt variation from 
admissions and deaths, which often showed comparable levels and patterns in oscillations over time 
but were out of phase with each other. This is likely, where due to a lack of England specific data we 
used delays from a worldwide linelist to specify the delay to any positive test as the same as that to 
admission, while the delay to death was estimated separately from UK data.  
We may also have mis-specified delays where delay distributions may themselves be spatially or 
temporally dependent. This was not accounted for but could have increased the accuracy of Rt 
estimation [41]. However, there is currently very little UK data on the time from case onset to 
confirmation of Covid-19 in any of a positive test, hospital admission, or death, from any point in the 
epidemic. We mitigated this by using a subsampled bootstrap, which incorporates our lack of certainty 
in the data.  
The data sources themselves may also have been inaccurate or biased, which would change the 
representation of the population we have assumed here. For example, we excluded data from other 
nations of the UK (Wales, Scotland and Northern Ireland) in our analysis, as these differed in both 
availability over time and in data collection and reporting practices [18,42]. English regional data may 
also contain bias where new parts of the population might be under focus for testing efforts, or the 
population characteristics of hospital admissions from Covid-19 may have changed over time with 
changes in clinical criteria or hospital capacity for admission. This would mean that an Rt estimate from 
these data sources would represent different source populations over time, limiting our ability to reliably 
compare against Rt estimates from other data sources. Where possible we highlighted this by 
comparing Rt estimates to known biases and changes in case detection and reporting. 
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Our approach is unable to make strong or causal conclusions about varying transmission, and 
assumptions about sampling and the representation of sub-populations remain implicit. Alternatively, 
varying epidemics in sub-populations could have been addressed with mechanistic models that 
explicitly consider transmission in different settings and are fitted to multiple data sources. However, 
these require additional assumptions, detailed data to parameterise, and may be time-consuming to 
develop. In the absence of data, the number of assumptions required for these models can introduce 
inherent structural biases. Our approach contains few structural assumptions and therefore may be 
more robust when data are sparse, or information is required in real-time. 
This work highlights the sensitivity of Rt estimates to assumptions about the underlying population of 
each data source. There is no clearly superior choice of data for estimating Rt, meaning choice should 
be guided by minimising relevant biases in the context in which the estimates will be used. Each data 
source is generated by separate sampling strategies, such as by community case detection or patient 
severity. Despite the robust reconstruction of the underlying transmission process from the reporting 
processes, there is additional information added by considering Rt estimates from different data sources 
in tandem. Although this can be difficult to interpret without specific knowledge of population structure 
and dynamics, this would be useful to clarify and target policy depending on transmission intensity by 
sub-population where access to high quality disaggregated data may not be not available in real time. 
In contrast, if policy were to be based on either a single or an averaged Rt estimate, it would be unclear 
what any recommendation should be and for whom.  
Future work could explore systematic differences in the influence of data source on Rt estimate by 
extending the comparison of Rt by data source to other countries or infectious diseases. Additionally, 
work should also clarify the potential for comparing Rt estimates in real-time tracking of outbreaks, and 
explore the inconsistencies in case detection over time and space, where a cluster of cases leads to a 
highly localised expansion of community testing, creating an uneven spatial bias in transmission 
estimates. These findings may be used to improve Rt estimation and identify findings of use for epidemic 
control. Based on the work presented here we now provide Rt estimates, updated each day, for test 
positive cases, admissions and deaths in each NHS region and in England. Our estimates are visualised 
on our website, are available for download, and are produced using publicly accessible code [43,44]. 
Tracking differences by data source can improve understanding of variation in testing bias in data 
collection, highlight outbreaks in new sub-populations and indicate differential rates of transmission 
among vulnerable populations, and clarify the strengths and limitations of each data source. Our 
approach can quickly identify such patterns in developing epidemics that might require further 
investigation and early policy intervention. Our method is simple to deploy and scale over time and 
space using existing open-source tools, and all code and estimates used in this work are available to 
be used or re-purposed by others. 
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Figures 
 
Figure 1. Epidemic dynamics across (A) England and (B-H) seven English National Health Service 
regions, 5th April through 27th August 2020. A1-H1: Daily counts of confirmed cases by data source, 
as centred seven day moving average. Counts marked with crosses indicate dates within weeks which 
averaged >5% test positivity (positive / all tests per week). Vertical dotted line indicates the start of 
national mass community testing on 3rd May. A2-H2: Estimates of Rt, (median, with 50% (darker shade) 
and 90% (lightest shade) credible interval), derived from each data source. Data sources include all 
test-positive cases, hospital admissions, and deaths with a positive test in the previous 28 days. 
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Figure 2. Dates on which Rt estimate crossed 1 after first epidemic peak, median and 90% credible 
interval, by data source for England and seven NHS regions. Dotted reference line on 23rd March 
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